Analyst firms · Citigroup · RMD

Citigroup RMD price target and rating history

ResMed Inc. (RMD) · Health Care

Citigroup rates ResMed Inc. (RMD) Neutral with a $235 price target, as of its latest action on Jul 13, 2026. It has published 8 rating actions on RMD since June 2021, including 2 upgrades and 5 downgrades. Across 5 firms with a RMD price target in the last 12 months, the median target is $235. Citigroup's target matches it.

Current rating
Neutral
Price target
$235
Median target, all firms
$235
Actions on RMD
8

Citigroup price target on RMD

$330$283$2352026
Citigroup price target on RMD, each point a stated target, September 2025 to July 2026.

Every Citigroup rating on RMD

How other firms rate RMD

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Canaccord GenuityHoldNov 2, 2026
RBC Capital MarketsOutperform$262Sep 15, 2026
Rothschild & Co RedburnNeutral$230Aug 19, 2026
CitigroupNeutral$235Jul 13, 2026
Morgan StanleyEqual-Weight$230Jun 17, 2026
Robert W. BairdNeutral$275Dec 16, 2025

Questions about Citigroup and RMD

What is Citigroup's price target for RMD?
Citigroup's latest stated price target for ResMed Inc. (RMD) is $235, from its action on Jul 13, 2026.
What is Citigroup's rating on RMD?
Citigroup rates RMD Neutral, a neutral rating, as of Jul 13, 2026.
When did Citigroup last change its view on RMD?
On Jul 13, 2026, Citigroup downgrades to Neutral from Buy, price target $235.
How does Citigroup's RMD target compare with other analysts?
Across 5 firms with a RMD price target in the last 12 months, the median target is $235. Citigroup's target matches it.

More RMD rating histories

All Citigroup ratingsRMD news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.